Synairgen - SNG

Synairgen to start trial of SNG001 in COVID-19


[Amy Schofield]

March 20, 2020

“Synairgen to start trial of SNG001 in COVID-19”

Respiratory drug discovery and development company Synairgen has received expedited approvals from the Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority (HRA) to conduct a trial of SNG001 in COVID-19 patients to potentially assist with the global outbreak of the virus. SNG001 is an inhaled formulation of interferon-beta-1a.

Would be nice to be able to get on this here with my ISA without having to go over to halifax and a basic account…

We missed the boat guys. Treatment announced this morning, share price already up 200%+ :frowning:

1 Like

Wow 300% plus rise.

500% now


Hi All,

Came across this really nice write up about the investment case for Synairgen. They’ve just entered their 3rd stage of clinical trials so some nice news could be on the horizon for their COVID treatment.

1 Like

Gutted for Synairgen & shareholders. ACTIV-2 Trial still ongoing.

1 Like